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880Objective: To compare the long-term reoperation rates among surgeons performing transatrial repair of
tetralogy of Fallot.
Methods: The data set of 675 patients undergoing transatrial repair of tetralogy of Fallot at 1 institution from
1980 to 2005 was analyzed for intersurgeon differences in the reoperation rates.
Results: A follow-up period>15 years was available for 5 surgeons, allowing for comparison (541 patients;
>80 patients/surgeon). The reintervention rate at 10 years varied from 8.8% (95% confidence interval [CI],
5.3%-14.5%) to26.7% (95%CI, 14.9%-44.9%; hazard ratio, 3.4;P¼ .001).Theproceduresof 1 surgeon resulted
in a reoperation rate of 10.5% at 20 years (95%CI, 5.4%-25.3%). The type of reoperation required varied among
the surgeons. One surgeon had had no reoperations for pulmonary artery stenosis. Of the 5 surgeons, 2 (surgeons 2
and 5) had equivalent overall 10-year reoperation rates (24.1%, 95% CI, 12.9%-42.3%; vs 26.7%, 95% CI,
14.9%-44.9%; P ¼ .32). Surgeon 5 had reoperation almost exclusively for right ventricular outflow tract
obstruction (20.6%; 95% CI, 12.4%-33.1%) and surgeon 2 for right ventricular dilation (17.4%; 95% CI,
7.8%-36.3%). None of the patients treated by surgeon 5 required implantation of a valved conduit.
Conclusions:An analysis of the reoperation rate during the long-term follow-up of transatrial repair of tetralogy
of Fallot identified variability in the outcomes among 5 surgeons. The analysis of these differences suggested
that an optimal amount of opening of the right ventricular outflow tract can lead to a decreased reintervention
rate. The analysis of intersurgeon variability in outcomes should be encouraged, because it will lead to
improvements in cardiac surgery outcomes. (J Thorac Cardiovasc Surg 2014;147:880-8)In a large proportion of the patients undergoing tetralogy of
Fallot repair, relief of the right ventricular (RV) outflow
tract (RVOT) obstruction necessitates a transannular
incision and patching of the hinge points of the pulmonary
valve.1-3 It has been estimated that 20 years after
undergoing Fallot repair, 30% to 40% of patients could
require the implantation of a valved conduit in their
RVOT because the created pulmonary insufficiency has
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The Journal of Thoracic and Cardiovascular SurgTwo main surgical techniques are available for repair of
tetralogy of Fallot: the transventricular technique, after
which the ventricular septal defect is closed through the
ventriculotomy; and the transatrial technique, after which
the ventricular septal defect is closed through the tricuspid
valve.2,7 It has long been suspected that patients would have
a reduced incidence of late RV dilatation if their RVOT
remained slightly restrictive after repair.1,3,8 The recent
publication of a long-term follow-up study and an animal
experiment have seemed to confirm this hypothesis.9,10 It
has been postulated that patients undergoing repair with
the transatrial technique would have a smaller incision on
the RVOT and, therefore, a reduced incidence of RV
dilatation requiring valvulation of the RVOT.1,8
Wehave recently reported the long-termoutcomes of all pa-
tients treated with a transatrial repair at the Royal Children’s
Hospital, Melbourne, with a policy of repair delayed beyond
the neonatal period.11 With the use of this technique and
policy, we observed hospital mortality of 1% and only 2
sudden deaths of 668 survivors of the repair. The veracity of
these data was ascertained in the National Death Registries.
Only15%of ourpatients required the implantation of avalved
conduit in their RVOT in the 20 years after repair.
We believed that under the generic term ‘‘transatrial
repair,’’ the surgeons of our team would vary in the methods
used to perform this operation, in particular, in the amount
of opening of the RVOT. We hypothesized that patientsery c March 2014
Abbreviations and Acronyms
CI ¼ confidence interval
HR ¼ hazard ratio
MRI ¼ magnetic resonance imaging
RV ¼ right ventricular
RVOT ¼ right ventricular outflow tract
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opening would have a greater risk of reoperation for RV
dilatation and those treated by surgeons practicing more
restrictive opening of the RVOT would have a greater risk
of reoperation for RVOT obstruction (Figure 1). To
determine the effect of this potential variation in practice,
we analyzed the intersurgeon variability in long-term
outcomes after transatrial repair of tetralogy of Fallot
performed within the same center.METHODS
The local hospital ethics committee approved the design of the present
study. The data set of a previous analysis of outcomes after transatrial repair
performed at the Royal Children’s Hospital was reanalyzed for differences
in late outcomes among surgeons, a parameter that had not been previously
investigated.11 The exclusion criteria were an associated atrioventricular
septal defect, pulmonary atresia, and double outlet right ventricle. After
1981, transatrial repair became the sole operative technique used in our
center. From 1980 to 2005, 675 consecutive patients underwent transatrial
repair of tetralogy of Fallot at our center. Their outcomes datawere recently
collected. Seven patients could no longer be located; the mean follow-up of
the remaining population was 11.7  6 years.
Mode of Referral
During the study period, the Royal Children’s Hospital has remained the
sole institution in Victoria, Australia, offering pediatric cardiac surgery,
providing this service for Victoria, South Australia, Tasmania, Northern
Territory, and, up to the 1990s, in Western Australia. During the study
period, acceptance for surgery and decision-making followed the same
rules. All cases referred for surgery by individual cardiologists were
discussed at the Royal Children’s Hospital case conference, in which all
cardiologists and surgeons present made decisions concerning acceptance
of surgery, type of surgery recommended, and timing of surgery. Cases
were allocated among the surgeons of the team by the head of the
department. Reoperations were preferably addressed to the surgeon who
had performed the initial operation if the surgeon was still working at
the center. Decisions concerning reinterventions were all discussed during
the same case conference. No set guidelines were used to determine the
need for reintervention. In recent years, magnetic resonance imaging
(MRI)-determined RV volumes have been used as the predominant criteria
for reintervention indicated for RV dilatation. Because of the unreliability
of the results of interventional catheterization for pulmonary artery origin
stenosis and the lower threshold to perform these noninvasive procedures,
only surgical procedures were considered as adverse outcomes.
Reoperations for congenital heart disease have all been performed at a
limited number of centers in Australia, all of which were contacted to
gather the follow-up data for the patients.
Policy and Surgical Technique
The center maintained a constant policy during the study period.
All patients had undergone repair after a minimum of 4 months of age.The Journal of Thoracic and CaPatients presenting with persistent cyanosis, spells, or small pulmonary
arteries before that age received a systemicopulmonary shunt. This policy
resulted in the prerepair palliation with shunting of 220 of the 675 patients
(33%). The median age at repair was 2 years (interquartile range,
15 months to 3.4 years) from 1980 to 1987 and 10 months (interquartile
range, 7-14) from 2000 to 2005. The details of the surgical technique
of transatrial repair have been previously described.7 RV pressure measure-
ments were not routinely performed at our center.
Statistical Analysis
Of the 675 patients, 7 did not survive to successful Fallot repair and 8
were excluded because of a requirement for a RV–pulmonary artery
conduit at repair. The remaining 660 patients had undergone surgery by
13 different surgeons, who had treated a total of 1, 1, 1, 5, 17, 17, 19, 39,
81, 84, 85, 127, and 164 patients. The surgical outcomes for the 5 surgeons
who had treated>80 patients each were compared for 2 separate endpoints.
The first was the risk of requiring a first reintervention for 3 indications: RV
dilatation, RVOT obstruction, and pulmonary origin stenosis. The second
was the risk of undergoing implantation of a valved conduit in the RVOT
at any point during the follow-up period. Kaplan-Meier analysis was
used to assess the freedom from reintervention for the various indications.
An examination of the risk factors for reintervention had been previously
performed in our overall cohort.11 Direct comparisons of the outcomes
among the surgeons, with adjustment for the primary confounders of age
at repair and previous palliation, were conducted using Cox regression
analysis. The postrepair RVOT gradient was not considered as a
confounder, because it was judged to be a consequence of the surgical
technique. The results of risk analyses accounting for the competing risk
of mortality were also examined; however, these were essentially the
same as those obtained by Cox regression analysis (owing to the small
number of late deaths after Fallot repair). To facilitate the comparison of
the patient characteristics treated by each of the 5 surgeons, the patients
treated by the 8 surgeons who each had had<80 repairs were combined
into a single reference group. We considered the distribution of RVOT
gradients immediately after Fallot repair for each surgeon to provide an
indication of the amount of opening of the RVOT. Differences in the
average gradient among the surgeons were tested using a nonparametric
test of equality of the median. The relationship between the risk of
subsequent reoperation and the RVOT gradient after Fallot repair was
examined using fractional polynomial regression analysis.RESULTS
Five surgeons had accumulated enough outcomes data to
allow a comparative analysis. These 5 surgeons had treated
541 patients, with an accumulated mean follow-up period
of 11.9  6.3 years. Surgeons 1 and 4 were operating
during the same era as surgeons 2 and 5. The comparison
of the patient characteristics treated by these 5 surgeons is
displayed in Table 1.
For the 5 surgeons compared, the 90 reinterventions were
classified according to their main indication as follows: RV
dilatation (n ¼ 29), RVOT obstruction (n ¼ 44), and
pulmonary artery origin stenosis (n ¼ 17). A comparison
of the freedom from intervention for each of these
indications for each of the 5 surgeons is displayed in
Figure 2.
The 10-year rate of first reintervention for any of these 3
indications varied from 8.8% (95% confidence interval
[CI], 5.3%-14.5%) to 26.7% (95% CI, 14.9%-44.9%).
This variation corresponded to a univariate hazard ratiordiovascular Surgery c Volume 147, Number 3 881
FIGURE 1. A smaller incision of the right ventricular outflow tract led to reoperation for right ventricular outflow tract obstruction and a larger incision to
reoperation for right ventricular dilatation. RV, Right ventricle; LV, left ventricle.
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surgeon with the greatest estimated proportion of
reinterventions at 10 years (surgeon 5) and the surgeon
with the lowest (surgeon 1). At 20 years after Fallot repair,
the lowest rate of reoperation had been achieved by surgeon
4, whose procedures resulted in a reoperation rate of 10.5%
at 20 years (95% CI, 5.4%-25.3%).
For all the 13 surgeons combined, the independent risk
factors predicting the occurrence of the 3 studied reopera-
tions were the postrepair RVOT gradient (HR, 1.3; 95%
CI, 1.2-1.5; P< .001), younger age at repair (HR, 0.7;
95% CI, 0.5-0.9; P ¼ .003), and previous palliation (HR,
2.1; 95% CI, 1.3-3.2; P ¼ .001). The other parameters
analyzed in the model that were not independent predictors
were patch type (treated autologous pericardium, untreated
autologous pericardium, and other type vs no patch), patch
of the pulmonary artery origin, and use of a transannular882 The Journal of Thoracic and Cardiovascular Surgincision. Eleven of the 17 patients requiring a first reopera-
tion for pulmonary artery origin stenosis had had previous
patching of the pulmonary artery origin. Similar results
applied when the data were restricted to the group of
patients treated by the 5 particular surgeons compared in
the present study (HR, 1.3 and P<.001 for the postrepair
RVOT gradient; HR, 0.6 and P ¼ .001 for younger age at
repair; and HR, 2.2 and P ¼ .002 for previous palliation).
The results of risk-adjusted analysis confirmed the range
of variation among reoperation rates of the surgeons. After
adjustment for patient age at repair and previous palliation,
the estimated relative reoperation rate between the
surgeons with the highest and lowest estimated proportion
of reoperations at 10 years was an HR of 2.7 (95% CI,
1.3-5.6; P ¼ .011).
Of the 5 surgeons, 2 (surgeons 1 and 4) had a similar rate
and pattern of reoperations. Their 20-year reoperation rateery c March 2014
TABLE 1. Patient characteristics stratified by surgeon
Characteristic
Surgeon
Reference group 1 2 3 4 5
Patients (n) 118 164 127 85 81 84
Female gender (%) 40 41 35 42 38 29
Years of repair (first to last) 1980-2004 1981-1994 1995-2004 1983-1998 1980-1992 1996-2005
Age at repair (y) 1.2 (0.8-1.7) 1.4 (0.8-2.7) 1.0 (0.7-1.3) 1.1 (0.9-1.4) 1.7 (1.1-3.2) 0.9 (0.5-1.2)
Hospital mortality (%) 2.5 0.6 0.8 0 0 0
Late mortality (%) 1.7 1.8 1.6 2.4 3.7 0
Previous palliation (%) 33 32 24 34 41 27
Monocusp (%) 11 5 14 8 4 5
Transannular incision (%) 63 49 72 68 58 81
Patch of PA origin (%) 25 16 17 13 19 19
RVOT gradient after ToF repair
(mm Hg) (P value)
0 (0-16) 0 (0-6.8; P ¼ .001) 9 (0-19; P ¼ .063) 0 (0-19; P ¼ .027) 0 (0-0; P ¼ .001) 0 (0-28; P ¼ .15)
Patch type
None 17 32 6 11 22 8
AP untreated 39 67 91 66 75 25
AP treated 16 0 0 3 0 64
Non-AP 28 1 3 20 3 3
Reoperation
Total RVOT obstruction, RV
dilatation, and PA stenosis
19 (16) 25 (15) 17 (13) 20 (24) 10 (12) 18 (21)
RVOT obstruction 8 (7) 14 (9) 3 (2) 8 (9) 4 (5) 15 (18)
RV dilatation 8 (7) 8 (5) 10 (8) 8 (9) 1 (1) 2 (2)
PA stenosis 3 (3) 3 (2) 4 (3) 4 (5) 5 (6) 1 (1)
Valved-conduit implantation 6 (5) 10 (6) 8 (6) 10 (12) 5 (6) 1 (1)
Data presented as%, median (interquartile range), or n (%). PA, Pulmonary artery; RVOT, right ventricular outflow tract; ToF, tetralogy of Fallot; AP, autologous pericardium;
RV, right ventricular.
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Dwas 10.5% (95% CI, 5.4%-25.3%) versus 16.7% (95%
CI, 10.9%-20.1%; HR, 0.8; 95% CI, 0.4-1.7; P ¼ .56).
The type of reoperation required varied among theFIGURE 2. Freedom from the first reintervention for the 5 surgeons who had p
indications of right ventricular obstruction, right ventricular dilatation, and
reoperations for pulmonary artery stenosis; black to red, proportion of reoperati
for right ventricular outflow tract obstruction.
The Journal of Thoracic and Caremaining surgeons. One surgeon had had no
reoperations for pulmonary artery stenosis, and surgeon 4
had a 10- and 20-year incidence of reoperation of 6.3%erformed>80 procedures and for the reference group of 8 surgeons for the
origin of the pulmonary artery stenosis. Black indicates proportion of
ons for right ventricular dilatation; red to green, proportion of reoperations
rdiovascular Surgery c Volume 147, Number 3 883
FIGURE 3. Freedom from implantation of a valved conduit in the right ventricular outflow tract for the 5 surgeons who had performed>80 procedures and
the reference group of 8 surgeons.
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D(95% CI, 2.7%-14.4%). Of the 5 surgeons, 2 (surgeons 2
and 5) had equivalent overall 10-year reoperation rates
(24.1%; 95% CI, 12.9%-42.3%; vs 26.7%; 95% CI,
14.9%-44.9%; HR, 1.4; 95% CI, 0.7-2.9; P ¼ .32)]. How-
ever, surgeon 5 had performed reoperation for RVOT
obstruction almost exclusively (20.6%; 95% CI, 12.4%-
33.1%) and surgeon 2 almost exclusively for RV dilatation
(17.4%; 95% CI, 7.8%-36.3%).
Of the 541 patients treated by the 5 surgeons studied, 34
required implantation of a valved conduit in their RVOT at
any stage during their follow-up. Of the 36 patients who had
undergone reoperation for RVOT obstruction before anyFIGURE 4. Relative hazard for reoperation for right ventricular outflow
tract (RVOT) obstruction and right ventricular (RV) dilatation as a function
of the RVOT gradient before hospital discharge after transatrial repair for
tetralogy of Fallot (ToF).
884 The Journal of Thoracic and Cardiovascular Surgreoperation for RV dilatation, pulmonary artery origin
stenosis, or implantation of a valved conduit, only 4 patients
required subsequent implantation of a valved conduit. The
comparison of freedom from valved conduit implantation
in the RVOT among these 5 surgeons is displayed in
Figure 3. The estimated proportion of reoperations at 10
years varied from 0% (surgeon 5) to 10.6% (95% CI,
3.9%-27%; surgeon 2). Estimates at 20 years were
available only for surgeons 1 and 4 and were 13% (95%
CI, 7.1%-22.9%) and 6.3% (95% CI, 2.7%-14.6%),
respectively.
For the 5 surgeons, the risk factors predicting implanta-
tion of a valved conduit were younger age at repair
(HR, 0.6; 95% CI, 0.4-0.9; P ¼ .033) and previous
palliation (HR, 2.1; 95% CI, 1.0-4.4; P ¼ .046). The other
parameters analyzed in the model that were not independent
predictors were the construction of a monocusp in the
outflow tract and the use of a transannular patch.
Differences were noted in the reoperation rates among
the 5 surgeons. After adjustment for patient age at repair
and previous palliation, the relative rate of valve implanta-
tion for surgeons 2 to 5 compared with surgeon 1 was as
follows: HR, 9.0 (95% CI, 2.6-31; P< .001) for surgeon
2; HR, 3.2 (95% CI, 1.2-8.5; P ¼ .023) for surgeon 3;
HR, 1.1 (95% CI, 0.4-3.2; P ¼ .91) for surgeon 4; and
HR, 1.4 (95% CI, 0.2-12; P¼ .79) for surgeon 5. Although
these results point to real differences in outcomes among
the surgeons regarding freedom from reoperation involving
valve implantation, some caution is required, given the
relatively small number of reoperations performed (34 for
all 5 surgeons).ery c March 2014
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repair and the risk of subsequent reoperation for RVOT
obstruction and RV dilatation is illustrated in Figure 4.
Surgeons varied in the spread of the RVOT gradient after
repair (Table 1), with both surgeon 1 (P¼ .001) and surgeon
4 (P ¼ .001) having a substantially lower residual gradient
compared with the reference group of surgeons.
DISCUSSION
Only limited examples have been published of compari-
sons of the long-term outcomes among individual surgeons.
The rare examples reported in recent studies have been
restricted to survival after rectal surgery and the rate of
incontinence after radical prostatectomy.12 The investiga-
tion of variations in outcomes among surgeons after
pediatric cardiac surgery has been limited to the study of
differences in hospital mortality for the most severe
conditions and medicolegal studies driven by public
health departments.13-18 We believed that the study of the
long-term outcomes after tetralogy of Fallot repair would
be the ideal subset to analyze the intersurgeon variability
in outcomes. Patients with tetralogy of Fallot will be
affected by varying degrees of obstruction of their outflow
tract; however, the association with other cardiac or
extracardiac anomalies has been rare. They are, therefore,
a relatively homogenous group of patients with an
occurrence of adverse events (reoperations) high enough
to allow for analysis. Our recruitment during the study
period was consistently based on an entire population,
eliminating potential referral bias. We used the same
standardized technique and the same strategy of early
palliation of cyanosed patients during the entire study
period. We hypothesized that the main difference among
the surgeons of our team would be the amount of RVOT
opening and that the type of reoperation performed would
vary accordingly. We assumed that the patients treated by
surgeons favoring a large RVOT opening would require
more reintervention for RV dilatation and those treated by
surgeons favoring a more restrictive opening would face a
greater risk of reintervention for RVOT obstruction.
We believe that our comparison of patient outcomes after
Fallot repair performed by various surgeons is more
informative of the best method to perfect this repair than
a report of the best outcomes by individuals or a group.
One could have suspected that differences in outcomes
would exist among surgeons, although this subject seems
somewhat taboo. All reoperation rates reported were better
than the published rates of reoperation after Fallot repair.
The present analysis, however, found that 1 surgeon could
achieve a 10% rate of reoperation, well below the current
expectations. One could wonder whether this remarkable
historical result could still be reproduced today. The median
age at repair of 1.7 years for his patients was older than the
current usual age at repair in most centers worldwide.The Journal of Thoracic and CaAlthough it might seem inappropriate or impractical to
perform Fallot repair later than 1 year of age, this low
reoperation rate could constitute an argument to complete
the repair later or at least after the neonatal age. It could
also be argued that patients treated in an early era may
have been subjected to less stringent criteria for reoperation,
leading to a lower rate of reoperation.We do not believe that
patients from the earlier era missed reoperation because of
premature death, because we found that only 2 patients
had died of sudden death in our entire series, a finding
confirmed by an analysis of the National Death Registries.11
In Australia, all patients with congenital heart disease are
followed up by a restricted number of teams and hospitals,
and all these hospital databases were searched for these
patients. We, therefore, believe that the ultimate 20-year
rate of reoperation reported is valid, although reoperations
would have occurred at a later stage in patients treated in
earlier era.
Themost striking finding of the present study was that the
main reason for reoperation varied among the surgeons,
pointing to a difference in technique within the same
generic term of ‘‘transatrial repair.’’ In particular, surgeons
2 and 5, who were operating in the contemporary period,
had a similar reoperation rate, but 1 performed reoperations
exclusively for RV dilatation and the other exclusively for
RVOTobstruction. The patients treated by the latter surgeon
(exclusively for RVOT obstruction) did not require
implantation of a valved conduit, at least not during the
study period. This finding seems to confirm the hypothesis
that a smaller opening of the RVOT is an effective measure
to prevent the deleterious consequences of longstanding
pulmonary regurgitation. At this stage, it would seem that
reoperation for RV obstruction does not expose patients
to a later increased risk of reintervention for valve
implantation. For this surgeon, this strategy resulted in the
reoperation of one fifth of his patients within 10 years.
Whether this rate of reoperation was justified is debatable,
if only 10% of the patients might require a valved conduit
implantation in the 20 years after repair with a larger
incision. Whether avoiding at all costs the implantation of
a valved conduit justifies the greater rate of early
reoperation for RV obstruction remains speculative. It is
also possible that the patients with restrictive outflow tracts
will have a limited exercise capacity. It is certain that all
efforts should be made to prevent the need for implantation
of a valved conduit in the late outcomes after Fallot repair.
Our study results have pointed to an ideal amount of
opening of the RVOT in Fallot repair, paving the way for
the development of strategies to achieve this goal.
Study Limitations
Ideally, we would like to have available for each patient
the pre- and postoperative MRI measurements of the
RVOT and RV volumes. However, consistent accumulationrdiovascular Surgery c Volume 147, Number 3 885
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obtain. The surgeons examined in the present study were
not all working in contemporary eras, limiting the validity
of the intersurgeon comparison. In particular, patients
treated in an earlier era were older at their repair and had
more frequently undergone previous palliation. Although
the analyses were adjusted for these differences, the
potential for differences in unmeasured confounders to
have influenced the results remained. Additionally, it would
not be impossible that the indications for reoperation varied
slightly during the study period. The main findings of the
present study should not have been affected by this
limitation. Patients treated in the early era were, in the
contemporary period, followed by the same teams as those
treated later and were, therefore, subjected to the same
indication criteria. Also, the main variations among the
surgeons were observed for surgeons 2 and 5, who were
operating during the same era.
The strengths of the study were the quality of our
follow-up, that Australian patients with congenital heart
disease are treated only at a limited number of centers,
and that the decision for reintervention for all patients
was determined by teams closely collaborating rather than
by individual surgeons.
CONCLUSIONS
The analysis of the reoperation rate during the long-term
follow-up of transatrial repair of tetralogy of Fallot
identified variability in the outcomes among surgeons. The
observed differences in the postrepair RVOT gradient among
surgeons suggest that variability could exist in the amount of
opening of the RVOT among surgeons. If so, this might
explain the observed intersurgeon variability in late out-
comes. If correct, an optimal amount of opening for the
RVOT might exist that would lead to a minimal rate of
reintervention. The analysis of intersurgeon variability in
outcomes should be encouraged, because it will lead to
improvements in the outcomes after cardiac surgery.
The authors would like to thank Mr Bill Reid for professional
preparation of the illustrations.
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Dr Marshall Jacobs (Philadelphia, Pa). This intriguing
analysis was based on the premise that analyzing the variation in
outcomes among individual surgeons who purport to be doing
the same operation could lead to a better understanding of the
essential features of the operation. In that respect, it is of general
interest and specific interest. Specifically, surgical repair of
tetralogy of Fallot is not a cure. The resultant physiology is not
completely normal, and many patients will require interventions
later in life.
Proponents of transatrial repair have postulated that it will
result in a reduced incidence of RV dilatation requiring later
implantation of a pulmonary valve. These results in Melbourne
for>3 decades are truly outstanding, with probably the lowestery c March 2014
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of this size. In this very large cohort, transannular patching was
performed in 75% of the cases. At 15 and 25 years, only 9%
and 15% had undergone implantation of a pulmonary valve,
respectively. At 25 years, the overall freedom from reintervention
was 25%.
Twelve years ago, at a meeting of this Association, a report was
presented of a series of patients who had undergone repair in
infancy of tetralogy of Fallot using a transventricular approach.
The presentation was discussed by an outstanding senior
surgeon from Melbourne who had made the following, not quite
excoriating, comment: ‘‘What worries me is that so little
information is given about the right ventricles of these patients.’’
Dr Roger Mee called for ‘‘.objective data from echocardiograms
and exercise testing.’’
Dr d’Udekem, in your report describing Melbourne’s large
consecutive transatrial repair cohort, you explained that
pulmonary valve replacement was usually undertaken when severe
pulmonary regurgitation was found in the presence of RV
dilatation, RV dysfunction, or symptoms of exercise intolerance.
Echocardiographic data at an average follow-up of 12 years
showed that pulmonary regurgitation was estimated to be severe
in 193 patients and moderate in 96 patients. These numbers
were far greater than the number who had undergone pulmonary
valve implantation.
Your analysis of the variation in the rate of reoperation
among surgeons is fascinating. One wonders, however, whether
freedom from various types of reintervention is the best
method to evaluate the effectiveness of an operative
strategy. Also, does it adequately discriminate among the results
achieved by the individual surgeons or is the rate of reoperation
actually a minimal estimate of those patients with troubled
right ventricles?
My first question is, would not the overall assessment and
the specific differences among the individual surgeons’
outcomes be even more informative if the analysis were based
on objective data of the RV size and function, regurgitant fraction,
and exercise capacity, rather than entirely on the rate of
reoperation?
Dr d’Udekem. Thank you very much. I think that is a very
excellent point. What we are concerned with is the functional
capacity of these patients.
MRI data are very difficult to obtain. We do not have in
Melbourne the research MRI facilities necessary to do a cross-
sectional study of our Fallot population. The echocardiographic
data are subject, as you know, to subjectivity. It would be difficult
to have a precise evaluation of RV function and RV volumes.
However, we do have actually exercise studies for the patients
from Victoria. I did not think to consider the difference among
the surgeons, but I will promptly do that as soon as I am back.
It is an excellent idea.
Dr Jacobs. Thank you. My second question relates to the
analysis of variation in outcomes among the individual surgeons
as a method of identifying the characteristics of an optimal
operative procedure. The competing objectives of relieving
outflow tract obstruction and minimizing the volume burden
imposed by pulmonary insufficiency will be influenced by both
the individual patient anatomy and the individual surgeon’sThe Journal of Thoracic and Catechnique. This suggests the possibility of a ‘‘sweet spot’’ at which
one does enough resection through a minimal incision to relieve
obstruction but does not cause severe pulmonary insufficiency.
You pointed out that the surgeon with the lowest incidence of
pulmonary valve replacement had a very high rate of patients
requiring reintervention for right ventricular outflow tract
obstruction. So, my second question is, has this study led you to
an assessment of what would be an acceptable gradient to leave
at the end of the operation? That is, where is the ‘‘sweet spot’’
between relief of obstruction and disruption of competence of
the pulmonary valve? Another way of asking, is if you took the
patients of surgeon 2 and surgeon 5 at late follow-up and had
them exercise, which group would perform better, the group
who had residual obstruction or the group who had had wide
open regurgitation after their initial repair?
Dr d’Udekem. It is a very important point, and I would like to
elaborate a little bit on this. The real answer is we do not know
exactly what we have to do with the outflow tract of these
patients. We know that RV dilatation is bad. You do not want to
put a valved conduit in these patients, and once you place the
first valved conduit, you start an eternal circle in which you are
going to have to keep performing reoperations on these patients.
When you study these patients with tetralogy of Fallot, they
go through different stages in life. They are born with RV
hypertrophy, they dilate, you put a conduit in them, the next
reoperation will be for obstruction, they start becoming
hypertrophic again, and what we do not know is at the end what
kind of heart does it make? We need the 40-year perspective.
Some of these patients we see have been coming back after
40 years with wrecked biventricular function, and if the origin of
their dysfunction was the initial RV dilatation, we should perhaps
avoid RV dilatation at all costs.
The old textbooks would tell you that it is bad to leave RV
outflow tract obstruction, but that is no longer the case with the
contemporary technique. We have presented, but not published,
our results with patients left with residual obstructions>40 mm
Hg. They have not died and they have been fairly asymptomatic,
not by an exercise study, but they have been fairly asymptomatic.
Thus, we do not know exactly whether we have to reoperate when
they have RVOT obstruction.
Now, there is something that can help you. You have to look at
the age, and I do not mean the age of the patient. I think you have to
look at the age of the surgeon. Thus, if you are a senior surgeon or
in the middle of your career, you can have as many reoperations for
RVOT obstruction as you want—you are still going to keep your
job. However, if you are a young surgeon and you are starting at
a new place, I would recommend not having a 25% rate of
reoperation at 5 to 10 years because I do not think you are going
to look good. So, if you want to look better, if I can have my extra
slide here, I can help you a little bit on how to look good, because
we plotted the echocardiographic data before hospital discharge
against the risk of reoperation, all reoperations and those for
dilatation and for obstruction. You will find that the HR of
reoperation was basically around 1 at a 15 to 20-mm Hg gradient.
Again, I do not say that we needed to do these reoperations for
RVOT obstruction. That was a historical series. These are the
indications you will receive from your mainstream cardiologists.
At a 30-mm Hg gradient, you will have a HR of 2, you haverdiovascular Surgery c Volume 147, Number 3 887
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have quadrupled the risk of reoperation.
Dr Jacobs. Well, I think we learned a great deal from this
interesting analysis. The concept itself is excellent, and I888 The Journal of Thoracic and Cardiovascular Surgrecommend your report to thosewhowant to pursue this interesting
topic. I hope in the future you will be able to analyze some
physiologic data and perhaps data on the length of the outflow tract
incision, which you speculated was important. Thank you.ery c March 2014
